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Muramic acid is a component of the peptidoglycan moiety of cell walls of all
bacteria and blue-green algae and is not found elsewhere in nature. A gas-liquid
chromatography-mass spectrometry assay for muramic acid in tissue is described.
The application of the method to the detection of muramic acid in tissues of rats
with streptococcal cell wall-induced polyarthritis is demonstrated. Because the
method has the potential to measure total bacterial biomass in tissue, it should
prove to be an important assay in elucidating the etiological role of bacterial
debris in chronic inflammatory diseases in humans.
Chronic, remittent, erosive arthritis is induced
in rats by a single intraperitoneal (i.p.) injection
of an aqueous suspension of group A streptococ-
cal cell wall fragments (4). The inflammation is
associated with localization and persistence of
cell wall antigen in the synovium and periar-
ticular tissues, as demonstrated qualitatively by
immunofluorescent techniques (4). The clinical,
radiological, and histological similarities be-
tween the experimental model and human dis-
ease (3, 4) have led to the hypothesis that
chronic inflammatory arthritides in humans,
such as rheumatoid arthritis or Reiter's syn-
drome, can result from the localization and per-
sistence of toxic, immunogenic, bacterial cell
wall fragments (4, 19, 20). To test this hypothesis
it is essential to be able to detect bacterial cell
walls in tissue, even though these cell walls may
be derived from unknown species.
Muramic acid is a component of the peptido-
glycan moiety of cell walls of all bacteria and
blue-green algae and is unique to these micro-
organisms (18). For this reason it provides a
naturally occurring internal label for bacterial
cell walls, and thus the detection of muramic
acid in tissue provides evidence for the presence
of bacterial cell wall debris. Although numerous
techniques have been published for the analysis
of muramic acid (2, 6, 8, 9, 11-13, 16), the only
method able to identify this compound at trace
levels in a complex matrix such as tissue is
gas-liquid chromatography-mass spectrometry
(GLC-MS).
In this report we describe a new GLC-MS
assay for muramic acid and illustrate the appli-
cation of the method to the detection ofmuramic
acid in tissues of rats with streptococcal cell
wall-induced polyarthritis. Because measure-
ment of muramic acid reflects the bacterial bio-
mass in tissue, it should prove useful in the study
of bacterial infections, as well as in elucidating
the possible etiological role of bacterial debris in
human arthritides.
MATERIALS AND METHODS
Preparation of bacterial cell wall fragments.
The preparation of bacterial cell wall fragments has
been described in detail (4). In brief, group A type 3
strain D58 cells were cultured in Todd-Hewitt broth
(BBL, Cockeysville, Md.) in a Virtis fermentor (Virtis,
Gardiner, N.Y.) and collected at early stationary phase
by continuous-flow centrifugation (Ivan Sorvall, Inc.,
Newton, Conn.). The washed cells were disrupted in
a Braun MSK cell homogenizer (Bronwill Scientific
Inc., Rochester, N.Y.), and the cell walls were collected
by centrifugation at 10,000 x g. The cell walls were
washed three times with pH 7.2 phosphate-buffered
saline (PBS) and treated with ribonuclease (0.025 mg/
mg of cell wall) at 370C for 4 h. They were washed
once with PBS, treated with trypsin (0.025 mg/mg of
cell wall) at 370C for 4 h, washed once again with PBS,
and then treated with papain (0.020 mg/mg of cell
wall) in 0.1 M phosphate buffer (pH 7.0) containing
0.001 M cysteine and 0.001 M ethylenediaminetetraa-
cetic acid (EDTA), at 370C for 4 h. They were washed
three times with PBS and then three times in water
and extracted three times with chloroform-methanol
(2:1). After this extraction they were washed once in
water, dialyzed against water for 24 h, and lyophilized.
To prepare cell wall fragments, the isolated cell walls
were suspended at 20 mg/ml in PBS, ultrasonicated
for 70 min in a Branson sonifier (model S125, Heat
Systems Ultrasonics, Inc., Plainview, N.Y.), and then
filtered through a series of sterile membrane filters
(Millipore Corp., Bedford, Mass.) 3.0, 1.2, and 0.45,gm
in size. In addition to removing any bacterial contam-
ination, the filtration also established the maximum
particle size of cell wall fragments.
Induction of arthritis and collection of tissue
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specimens. Female Sprague-Dawley rats, each
weighing approximately 100 g, were given a single i.p.
injection of group A streptococcal cell wall fragments
suspended in PBS. The dose of cell wall injected
contained 60 #g of rhamnose per g of body weight.
This amount is equivalent to approximately 20 mg of
cell wall per rat. Experimental animals and parallel
controls injected with PBS were sacrificed at 3, 6, and
8 days after injection. After sacrifice the right fore leg
from each animal was amputated, the skin was re-
moved, and the carpus, metacarpus, and surrounding
subcutaneous tissues were excised and frozen imme-
diately at -20'C. Samples of liver and spleen were
also stored at -20'C until analysis.
Sample preparation for GLC-MS. Tissues were
weighed and homogenized in 10 ml of water in an
Omnimixer (Sorvall). The homogenate was dialyzed
against 6 liters of water for 16 h at 4VC. The water was
changed at 8 h. A few drops of chloroform were added
to the water to inhibit bacterial growth. The dialyzed
samples were Iyophilized and reweighed. A 30-mg
amount of dried sample in 1.0 ml of 2 N sulfuric acid
was placed in a reaction tube with an adjustable Teflon
plunger (Pierce, Rockford, Ill.). The tubes were evac-
uated and flushed with nitrogen. The sample was then
heated at 100'C in a heating module (Pierce) for 3 h
and then cooled in an ice bath. A 10-,ug portion of
muramic acid in 1 ml of 2 N sulfuric acid was subjected
to the same treatment through the entire procedure.
A 5-ml amount of 20% di-N-octylmethylamine in chlo-
roform was added to the sample. The sample was
shaken, and, after 20 min, the aqueous phase was
removed and centrifuged at 1,000 rpm for 10 min. The
muramic acid in the aqueous phase of the tissue sam-
ples was partially purified by thin-layer chromatogra-
phy (TLC). Exactly 0.4 ml of the aqueous phase was
streaked on a 1-mm-thick preparative silica gel TLC
plate with a preabsorptive area (Pierce). The plate
was dried and chromatographed in a butanol-ethanol-
water system (50:32:18). The RI value of muramic acid
on TLC is 0.5, but the exact position of muramic acid
was confirmed on each analysis by chromatographing
a muramic acid standard and identifying it with nin-
hydrin spray reagent. After chromatography the plates
were dried again, and an area ±0.8 cm from the Rf of
muramic acid was loosened with a razor blade and
removed by suction into a 10-ml glass pipette plugged
with glass wool. A 12-ml amount of chloroform was
passed through the packed pipette to remove lipids
released by hydrolysis, and this eluent was discarded.
Muramic acid was eluted from the pipette with 12 ml
of methanol-water (7:3) under nitrogen pressure. A 5-
.ug portion of glucosamine as an internal standard was
added to the samples, and the samples were evapo-
rated under nitrogen in a 55°C water bath (N-Evap,
Organomation, Northborough, Mass.). They were then
reacted with 5 mg of sodium borohydride overnight at
4°C to destroy the anomeric center. Destruction of the
anomeric center eliminates occurrence of multiple
peaks upon gas chromatography. A 3-ml amount of
acetic acid-methanol (1:200) was added to the sample
and evaporated under nitrogen. This process was re-
peated five times. This step converts borohydride into
trimethylborate, which is removed by evaporation.
Borate, if present, inhibits the subsequent acetylation
reaction. The samples were lyophilized for 3 h, 300 t1
of acetic anhydride was added, and the samples were
heated for 13 to 16 h at 100°C in reaction vials with
screw caps and Teflon-silicone disks (Pierce) in a
heating module. This step converts alditols into the
volatile alditol acetates (17). The samples were then
evaporated to dryness under nitrogen. One milliliter
of water and 1 ml of chloroform were added to the
derivatized sample, the emulsion was centrifuged, and
the chloroform phase was removed and evaporated to
dryness. This step removes polar compounds such as
salts and amino acids. The derivatized sample was
dissolved in 20 .1 of chloroform, and 2 id was analyzed
on a 3920B gas chromatograph equipped with a flame
ionization detector and M2 calculating integrator (The
Perkin Elmer Corp., Norwalk, Conn.). Chromatogra-
phy was done on a glass column (6 feet by 2 mm)
packed with 3% SP2340 on 100/120 mesh Supelcoport
(Supelco, Bellefonte, Pa.) with a temperature program
having an initial temperature of 200°C increased at a
rate of 4°C per min to a final temperature of 240°C.
The helium carrier gas flow was 40 ml/min. The
detector and injector were held at 250°C. The concen-
tration of muramic acid per gram (wet weight) of
tissue was calculated as follows: C = M x G, x X/G
x M, x W, where C = micrograms of muramic acid
per gram of wet tissue;M = area of muramic acid peak
in tissue chromatogram; G = area of glucosamine peak
in tissue chromatogram; M, = area of muramic acid
peak in standard chromatogram; G. = area of gluco-
samine peak in standard chromatogram; X = micro-
grams of muramic acid in standard solution; and W
= weight of wet tissue analyzed.
Mass spectra were obtained on a Micromass 7070F
(VG Micromass, Winford, England) mass spectrome-
ter interfaced with a Sigma 3 gas chromatograph (Per-
kin Elmer). The mass spectrometer was equipped with
an 8-channel multiple ion detection unit and a VG
203F Data System equipped with selective ion record-
ing software package. To obtain quantitative trace
analysis by GLC-MS, selective ion monitoring for
peaks mle 168, 210, and 228 was performed.
Reagents for GLC. Reagents and sources were as
follows: chloroform, methanol, and butanol, all glass
distilled, from Burdick and Jackson, Muskegon, Mich.;
ethanol, glass distilled, from MCB, Cincinnati, Ohio;
acetic acid, ultrex grade, from Baker, Phillipsburg,
N.J.; di-N-octylmethylamine, ICN, Plainview, N.Y.;
acetic anhydride from Applied Science Laboratories,
State College, Pa.; sodium borohydride and sulfuric
acid from Fisher Scientific Co., Pittsburgh, Pa.; mu-
ramic acid from P-L Biochemicals, Milwaukee, Wisc.;
D-glucosamine hydrochloride from Calbiochem,
La Jolla, Calif.; and water, which was double distilled.
RESULTS
The alditol acetate method (17) was chosen
for derivatization of muramic acid since it pro-
duces a single peak on gas chromatography, in
contrast to other methods such as silylation (2).
This makes interpretation ofthe chromatograms
simpler and also increases sensitivity. The aldi-
tol acetate of muramic acid (pentaacetyl mu-
ramicitol) has a molecular weight of 463. In
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FIG. 1. Chemical ionization (methane) mass spectrum ofpentaacetyl muramicitol.
preliminary experiments the chemical ionization
mass spectrum of derivatives of muramic acid
was obtained by using methane as the ionizing
gas (Fig. 1). This analysis was done to look for
the presence of a molecular ion (M) with an m/
e of 463, which would confirm the chemical
nature of the derivative of muramic acid. A
molecular ion of mle 463 was not seen, but mass
ions at 446 and 404 were detected. The ion at
446 would be produced by the derivative gaining
a hydrogen ion and losing water (MH-H20),
whereas the ion at 404 would be obtained by loss
of an acetyl group (M-CH3CO2.)'. Alditol ace-
tates are extremely unstable even under mild
ionization conditions, such as chemical ioniza-
tion, and commonly decompose, losing water or
acetyl groups (10). Thus, the data support the
conclusion that pentaacetyl muramicitol was
produced.
Samples of spleen and liver from arthritic rats
injected up to 8 days previously with group A
streptococcal cell wall fragments and samples
from normal controls were analyzed by the al-
ditol acetate method described. A peak having
a retention time of 818 s, equal to that of mu-
ramic acid derivatized in an identical fashion,
was resolved in the gas chromatogram of tissues
from arthritic rats; however, this peak was not
present in samples of normal rat tissues (Fig. 2).
Although these data alone are strong evidence
that this peak is derived from muramic acid, it
is possible that inflamed tissue contains a com-
pound having a retention time equal to that of
muramic acid and that this compound is not
present in normal tissue. Accordingly, the peak
resolved in the gas chromatogram of tissue from
arthritic rats was analyzed by GLC-MS. The
electron ionization mass spectrum of this mate-
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FIG. 2. Gas chromatogram of alditol acetate de-
rivatives of (A) extract ofspleen from animal injected
i.p. 6 dayspreviously with cell wall fragments and (B)
extract of normal spleen. Peak 1 corresponds to mu-
ramic acid; peak 2 corresponds to the internal stan-
dard glucosamine. Other peaks are derived from
tissue components.
muramic acid, which confirms the identity of the
material as muramic acid (Fig. 3).
Having definitively confirmed the presence of
muramic acid in the spleens and livers of rats
injected i.p. with streptococcal cell walls, we next
looked for the presence of muramic acid in ar-
thritic joints where it would only be present in
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FIG. 3. (A) Electron ionization mass spectrum of the muramic acid peak in a gas chromatogram of an
extract of spleen from an animal injected 8 days previously with cell wall fragments. (B) Pentaacetyl
muramicitol reference standard.
spectrum of muramic acid contains prominent
mass ions at m/e 168, 210, and 228. Therefore,
instead of obtaining a complete mass spectrum,
selective ion monitoring was done to detect the
ions 168, 210, and 228 in peaks resolved from the
gas chromatogram. This results in a 1,000-fold
increase in sensitivity, because the instrument is
focusing on only these three ions rather than on
the entire spectrum (22). By this method, mu-
ramic acid was detected in joints from arthritic
animals, but not normal controls (Tables 1 and
2).
Many questions arising in this rat arthritis
system, such as differences in arthropathogen-
icity of differing particle sizes of group A cell
wall fragments (A. Fox, R. Brown, and J. H.
Schwab, IX Eur. Cong. Rheum. p. 203, 1979)
and differences in susceptibility of various
strains of rat to development of arthritis (1), are
TABLE 1. Quantitation ofmuramic acid in spleens
of rats by GLC













a Rats were injected i.p. 6 days previously with 20
mg of group A streptococcal cell wall fragments. Tis-
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TABLE 2. Quantitation ofmuramic acid in joints of
rats by GLC-MS employing selective ion monitoring
Muramic acid (ug)/g (wet wt) of
Animal Days post- tissue
no.' injection
m/e 168 m/e 210 m/e 228
1 3 0.9 0.8 0.8
2 3 0.4 0.4 0.4
3 8 0.4 0.3 0.4
4 8 0.2 0.2 0.2
5 8 1.0 0.9 0.9
6 8 0.7 0.6 0.7
a Rats were injected i.p. with 20 mg of group A
streptococcal cell wall fragments.
b Calculated from the area of the respective ions in
a derivatized extract of joint tissue, compared to the
corresponding ion areas in a muramic acid standard.
Background values for each ion, obtained with extracts
from normal rat joints, have been subtracted.
probably related to persistence and localization
of cell wall debris. Therefore, it is necessary not
only to be able to detect muramic acid but to
measure its concentration in tissue. The quan-
titation of muramic acid in spleens of rats killed
6 days after i.p. injection of cell wall fragments
is shown in Table 1. Tissues from control rats,
injected with PBS, had no detectable muramic
acid. The muramic acid in extracts of joints of
rats injected with cell wall fragments is shown
in Table 2. The data in Table 2 were obtained
with selective ion monitoring and were similar
whether the data were based on ions 168, 210, or
228. This provides evidence of the specificity of
the method for muramic acid.
The coefficient of variation of the entire assay
was 19%. This was measured with six replicates
of the same normal liver sample containing
added muramic acid and glucosamine as an in-
ternal standard. The recovery of muramic acid
in tissue was 83.4%. This was determined with
six replicate tissue samples containing added
muramic acid, compared with six replicate sam-
ples ofmuramic acid alone. Both sets of samples
contained glucosamine added as an internal
standard.
DISCUSSION
After local or systemic injection, bacterial cell
wall structures can persist in tissue and cause
chronic inflammation in experimental animals
(4, 14, 15, 20). On the basis of these earlier
studies we have proposed that human diseases,
such as rheumatoid arthritis, may result from
the localization and persistence of bacterial cell
wall debris (4, 19, 20). Such debris could be
derived from a variety of bacterial species. This
hypothesis can be tested by analyzing tissue
INFECT. IMMUN.
samples chemically for components unique to
bacterial cell walls. Muramic acid is such a com-
ponent, being present in cell walls of all bacteria
but found nowhere else in nature. A new GLC-
MS assay for detection and quantitation of mu-
ramic acid in tissues is presented here, and the
method is applied to detect muramic acid in
tissues of rats previously injected with group A
streptococcal cell wall fragments.
Other methods for the detection of bacterial
cell wall in tissue such as external labeling with
125I (5), fluorescein (7), or rhodamine (21) or
internal labeling with "C (R. S. Jones and J. R.
Ward, Arth. Rheum. 5:650-651, 1962), present
several problems. These include uncertainty of
the precise component which is labeled, possible
alteration of biological properties by the conju-
gation, and uncertainty that the label remains
associated with cell wall structures in vivo. Ob-
viously, these methods are of no use in the study
of human patients. Detection of cell wall anti-
gens by immunofluorescence or radioimmunoas-
say can be applied to human tissue specimens,
but the specificity of the antigen being sought
must be known before testing. In addition, host
antibody could block the antigenic site (23) or
the host may modify immunodeterminants on
cell wall antigens. A chemical assay of muramic
acid does not suffer from these constraints. The
obvious advantage of the detection of this nat-
ural internal label is that the presence of cell
wall debris from any bacterial species can be
detected and quantitated in human as well as
animal tissues.
The GLC-MS technique has the potential sen-
sitivity of 10-'5 mol. The limitations are imposed
by the background material from tissue compo-
nents. We are presently employing TLC to re-
move a great deal of this background. However,
TLC is time consuming, taking about 6 h, and
the subsequent elution ofmuramic acid from the
silica gel plates is tedious. Furthermore, the
precision of quantitation is limited by the selec-
tion of an appropriate internal standard. Ideally
this standard should have an R1 identical to that
of muramic acid on TLC and be derivatized to
a volatile form by the alditol acetate method,
but it should be well resolved from muramic
acid by GLC-MS. Stable isotopic isomers ([13C]
muramic acid) or steric isomers (lactyl galactos-
amine or lactyl mannosamine) of natural mu-
ramic acid would be ideal but we have not yet
been able to obtain them. The lack of a suitable
internal standard has necessitated adding the
glucosamine standard subsequent to elution of
the samples from the silica gel. This reduces
precision of quantitation. Glucosamine is used
as an internal standard since glucosamine de-
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rived from tissue is removed on TLC (only ma-
terial of Rf = 0.5 is eluted and glucosamine
remains at the origin), and muramic acid and
glucosamine are well resolved by gas chromatog-
raphy. Due to the problems mentioned we are
currently developing an alternative to TLC and
synthesis of a suitable internal standard.
The preliminary work presented here on the
detection of bacterial cell walls in rat tissues
shows that the assay has the potential for detec-
tion of this material in human tissue. This ap-
proach can thus contribute to the study of hu-
man arthritides by confirming that bacterial cell
debris is an etiological factor. Furthermore, the
demonstration that it is possible to detect one
bacterial component in mammalian tissue en-
courages the development of techniques for the
detection of other components characterizing
subsets of bacteria. For example, diaminopimelic
acid is found mainly in gram-negative and acid-
fast bacteria, 2-keto-deoxyoctonic acid is found
in gram-negative bacteria, and mycolic acid is
found in mycobacteria, nocardia, and corynebac-
teria. Such chemical analyses are potentially
useful in investigation of the pathogenesis of
bacterial infections.
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